October 12, 2010

Lupin Pharmaceuticals received regulatory approval last week for its generic antihypertensive agents, the drug maker...

October 11, 2010

Actavis has received regulatory approval from the Food and Drug Administration for its high blood...

October 11, 2010

The Food and Drug Administration has turned down an application from a company seeking approval...

October 11, 2010

The Food and Drug Administration has approved a new formulation of a drug for osteoporosis...

October 10, 2010

Humanity has come a long way since the days when people thought sickness came from...

October 10, 2010

While the fact that two Food and Drug Administration advisory committees collectively voted 15 opposed...

October 10, 2010

For more than 125 years, the Consumer Healthcare Products Association has helped over-the-counter medicine providers...

October 10, 2010

Johnson & Johnson is set to buy the remaining portion of Dutch biotech company Crucell...

October 10, 2010

Remote management of diabetes increasingly is becoming a reality to day with WellDoc’s Diabetes-Manager system,...

October 7, 2010

Clinical trial data indicating an increased risk of heart attack and stroke has led to...

October 4, 2010

The Food and Drug Administration has approved a generic treatment for cough and upper respiratory...

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

October 4, 2010

The Food and Drug Administration has approved a generic drug for HIV made by a...

October 4, 2010

Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...

October 4, 2010

Generic drug maker Watson Pharmaceuticals is seeking approval for a generic treatment for Parkinson’s disease,...

October 3, 2010

The Food and Drug Administration turned down a regulatory approval application from Johnson & Johnson...

October 3, 2010

The Food and Drug Administration has approved a generic chemotherapy drug made by Mylan....

October 3, 2010

The Food and Drug Administration has awarded almost $3 million for tuberculosis research, the agency...

October 3, 2010

The Food and Drug Administration has approved a nonstimulant drug for treating attention deficit hyperactivity...

September 30, 2010

The Food and Drug Administration is cracking down on companies that sell an unapproved treatment...

September 30, 2010

McNeil products soon will repopulate shelves, Johnson & Johnson chairman and CEO Bill Weldon shared...

September 29, 2010

The biotech division of Johnson & Johnson is hoping to expand the use of a...

September 29, 2010

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made...

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...